CXH Is Pricing the Tender, but Proration Owns the Clock

Summary: MFS Investment Grade Municipal Trust is trading near $8.35 against a May 12 tender for up to 50% of its shares at 99% of NAV. The market appears to see a clean discount-capture event; the real trade is a proration and residual-discount problem before CXH is folded into MFS Municipal Income Trust.

Opportunity Ranking

Rank	Idea	Discovery Lane	Why It May Be Best Now	Evidence Freshness	Catalyst Window	Asymmetry	Main Reason to Reject
1	CXH tender before MFM reorganization	closed-end fund / forced flow	CXH trades at a tight discount before a 50% NAV tender, but the residual shares may inherit the wider MFM discount after the merger	MFS tender materials, CEFConnect NAV, live quote checked May 7, 2026, Singapore time	Tender expires May 12, 2026	Small positive only if proration is favorable; negative if residual trades like MFM	Edge is thin and NAV can move before pricing
2	CGBD below-NAV issuance vote	BDC governance / credit	Carlyle Secured Lending trades at a deep discount to NAV while seeking permission to issue below NAV	Proxy materials and Q1 NAV references; live quote checked May 7, 2026, Singapore time	Special meeting on June 9, 2026	Downside optionality if investors ignore dilution authority	Vote approval may be a governance tool, not an imminent issuance plan
3	SLNO cash tender spread	merger arbitrage / HSR-cleared tender	Soleno trades just below Neurocrine's $53 cash tender after HSR clearance	Offer materials, HSR clearance release, live quote checked May 7, 2026, Singapore time	Tender expires May 15, 2026	Clean but tiny gross spread	Spread is too small for operational and settlement risk

Selected opportunity: CXH tender before the MFM reorganization.

Why this one now: The catalyst is dated, the price/NAV inputs are visible, and the mispricing sits in mechanics rather than story. That is exactly where small closed-end fund trades can look safer than they are.

What should surprise the reader: The tender price is not the end value. If half the shares are accepted near 99% of NAV and the other half reopens at a discount closer to MFM's market discount, the blended economics can be worse than the headline tender spread.

Why This Is the Best Opportunity Right Now

CXH is not a broad municipal-bond view. It is a dated, mechanical setup with three hard facts.

First, MFS announced a tender for up to 50% of CXH's outstanding common shares at 99% of NAV, with an expiration scheduled for 5:00 p.m. Eastern time on May 12, 2026. If more than 50% of shares are tendered, purchases are expected to be prorated. The fund's board has not made a recommendation to tender or hold. MFS tender release

Second, shareholders approved the reorganization of CXH and two other MFS municipal funds into MFS Municipal Income Trust, ticker MFM, on April 8, 2026. The tender is therefore not a standalone value event; it is a pre-merger liquidity valve. MFS reorganization release

Third, the current discount is already tight. CEFConnect showed CXH at $8.35 against NAV of $8.53 as of May 5, 2026, a 2.17% discount, compared with a one-year average discount of 6.73%. CEFConnect CXH snapshot

That makes the setup narrow but useful: the market is pricing a tender event, while the payoff depends on proration, NAV movement, and the discount where the untendered stub trades.

What Should Surprise the Reader

The obvious arithmetic says 99% of $8.53 is about $8.44, above the $8.35 market price. That is not the trade. The trade is the blended claim on accepted and rejected shares.

If every holder tenders, only half the position is bought. The other half remains exposed to municipal closed-end fund discount risk, leverage, rate moves, and the pending conversion into MFM. That residual piece matters more than the headline $0.09 tender spread.

MFM is the receiving fund. It trades with its own discount history and shareholder base. CEFConnect showed MFM at $5.49 versus NAV of $5.99 as of May 5, 2026, an 8.37% discount. Its one-year average discount was 9.99%. CEFConnect MFM snapshot

If CXH residual holders are effectively migrating into that discount regime, a fully tendered position can have less upside than the tender price suggests.

The Setup

CXH is a small leveraged municipal closed-end fund. CEFConnect listed 8.2 million common shares outstanding and a $68.5 million market capitalization as of May 5, 2026. Average daily volume was about 27,900 shares, roughly $221,000 in traded value. This is a small liquidity pocket, not an institutional-size unwind venue.

The tender sits inside a larger cleanup. MFS said shareholders approved reorganizations in which MFS High Yield Municipal Trust and CXH will reorganize into MFS Municipal Income Trust, and MFS High Income Municipal Trust will also reorganize into MFS Municipal Income Trust. MFS reorganization release

The tender gives CXH holders a partial cash exit near NAV before that consolidation. The fund also announced a partial optional redemption of preferred shares scheduled for May 8, 2026, which matters because leverage and preferred financing affect NAV sensitivity. MFS preferred redemption release

The Market Price

The current market setup is tight.

Market Level	Value	Timestamp	Source
CXH share price	$8.35	Last live quote checked May 7, 2026, 00:38 Singapore time	Live finance quote feed
CXH NAV	$8.53	May 5, 2026	CEFConnect
CXH discount to NAV	2.17%	May 5, 2026	CEFConnect
Tender reference	99% of NAV	Tender expires May 12, 2026	MFS tender release
Indicative tender value using $8.53 NAV	$8.44	Computed from May 5 NAV	0.99 x $8.53
MFM share price	$5.49	Last live quote checked May 7, 2026, 00:26 Singapore time	Live finance quote feed
MFM NAV	$5.99	May 5, 2026	CEFConnect
MFM discount to NAV	8.37%	May 5, 2026	CEFConnect

The visible spread from $8.35 to the indicative $8.44 tender price is about 1.1%. That is before proration, NAV movement, tender fees, execution slippage, taxes, and the residual discount.

The Positioning

The direct positioning evidence is incomplete. There is no real-time data showing exactly how much CXH is held by tender arbitrage accounts versus income-oriented closed-end fund holders.

The observable clues point to a mixed base.

CXH is small, thinly traded, and near a corporate-action deadline. CEFConnect's average daily value of roughly $221,000 means even modest arbitrage buying can push the fund toward the tender value. The current 2.17% discount is also much tighter than its one-year average discount of 6.73%, which suggests the tender has already pulled the price toward NAV.

The other side is income-fund gravity. After the tender and reorganization, residual holders are not entitled to a permanent 99% NAV exit. They own municipal closed-end fund exposure, with leverage and discount risk. MFM's own discount is the warning label.

The positioning claim should be kept modest: the setup is not obviously crowded in size, but the price already reflects a substantial amount of tender-event demand.

The Catalyst

The catalyst path is clear.

May 8, 2026: CXH's partial preferred-share redemption is scheduled.
May 12, 2026: CXH tender expires, unless extended.
After expiration: the fund announces accepted shares, proration, final purchase price, and settlement mechanics.
Later in 2026: CXH is expected to be reorganized into MFM after the already approved merger process is implemented.

The first price test is not whether the tender exists. It does. The test is whether accepted-share economics and residual trading value justify the pre-tender price.

The Gap

The market appears to be pricing CXH as a low-risk tender capture. The key disagreement is that a 50% tender is not a 100% exit.

The simplest approximation:

If all shares are accepted at 99% of NAV, the current price is slightly cheap.
If only half are accepted and the rejected half trades near CXH's current 2% discount, the edge is marginal.
If only half are accepted and the rejected half trades closer to MFM's 8% to 10% discount regime, the setup turns negative.

The tender creates a floor for part of the position. It does not create a floor for the whole position.

The Payoff Map

The payoff is path-dependent and small. That matters. This is a trade where execution discipline can change the conclusion.

One possible expression is a tender-confirmed long in CXH common, only for accounts that can tender reliably before the broker cutoff and tolerate proration. The cleaner alternative is no trade at the current quote, then reassess the residual after tender results.

An outright long without tender capability is the wrong expression. It leaves the investor with the residual discount risk and loses the one mechanism that made the setup interesting. A short is also poor for most accounts because the borrow, dividend, tender mechanics, and thin liquidity can overwhelm a small expected edge.

Price Target and Probability Map

Scenario	Probability	Target / Level	Return / Payoff	Time Horizon	Conditions Required	Evidence Quality
Top Case	30%	$8.47 blended value	+1.4%	May 12 tender through settlement	More than 50% accepted or residual trades near a 2% to 3% discount to NAV	Medium
Base Case	45%	$8.38 blended value	+0.4%	May 12 tender through settlement	50% proration, stable NAV, residual trades around a 3% to 4% discount	Medium
Bottom Case	25%	$8.16 blended value	-2.3%	May 12 tender through post-tender trading	50% proration, municipal NAV slips, residual trades closer to MFM's wider discount	Medium
Invalidation / Stop Condition	n/a	Below $8.12 or tender extension/cancellation	Thesis break	Immediate through tender expiration	NAV drop, tender terms change, broker cannot tender, or residual discount risk overwhelms tender value	High

Probability-weighted expected value: $8.35 per current CXH share, roughly flat versus the $8.35 market price. This is before account-level fees, taxes, broker deadlines, and slippage.

Current market price / level: CXH $8.35, last live quote checked May 7, 2026, 00:38 Singapore time. CXH NAV $8.53 as of May 5, 2026.

Timestamp: Research compiled May 7, 2026, 01:15 Singapore time.

Primary instrument: CXH common shares, with tender participation.

Alternative expressions considered: MFM common as the residual fund, outright long CXH without tender rights, post-tender residual purchase, and short CXH. Outright long without tender rights and short CXH are both inferior expressions at the current spread.

Confidence: Medium.

What Could Go Wrong

The weak point is not the tender document. The weak point is the rejected share.

Municipal NAV can move before the purchase price is finalized. Leverage can magnify that move. The preferred-share redemption may lower one type of leverage, but it does not remove duration, credit, or discount risk from the common.

Proration can be severe if tender arbitrage accounts and income holders both submit shares. Broker deadlines can arrive before the fund's official deadline. Small funds can gap on low volume. Taxes can also change realized economics for taxable accounts.

The cleanest invalidation is mechanical: if an account cannot tender, the trade should not be treated as a tender trade. The second invalidation is price: above the low $8.30s, the expected value becomes too thin under the base assumptions.

Risk Audit

Strongest counterargument: The market may already understand the proration risk and still be right because post-tender CXH residual shares could trade tighter than MFM until the reorganization is completed. If so, the top and base cases are too conservative.

Most fragile assumption: The residual discount. A shift from a 3% residual discount to an 8% residual discount changes the trade from small positive carry to negative expected value.

What the market may already know: Tender mechanics are public, NAV is published, and merger approval has already been announced. There is no information advantage in the headline.

What could make the trade lose money even if the thesis is directionally right: NAV can fall, proration can cap the accepted portion, and the rejected shares can trade down before the investor can exit.

Liquidity / execution risks: CXH is small and trades lightly. Limit-order discipline matters. Tender submission deadlines are broker-specific.

Leverage risks: CXH is leveraged municipal credit exposure. Duration and credit moves can hit NAV before the tender purchase price is set.

Information reliability risks: CEFConnect NAV and discount data can lag by one business day. Live quote data can be thin. Final tender price depends on the fund's NAV calculation at expiration.

Invalidation trigger: Tender extension, tender cancellation, inability to tender, NAV falling enough to erase the tender spread, or CXH trading above the expected blended value.

Publish / revise / reject recommendation: Publish as a mechanical trade note, not as a high-upside recommendation.

Bottom Line

CXH is not mispriced because the tender exists. It may be mispriced because the market is giving too much credit to the accepted half of the position and too little attention to the rejected half. The best expression is narrow: tender-capable CXH common only below the expected blended value, with no trade as the default at prices that already discount the tender. The cleaner opportunity may arrive after May 12, when the rejected residual has to trade on its own facts.